menu
    • menu

    Company profile for Epitopea

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Epitopea is a biotechnology company pioneering novel cancer immunotherapies. Focused on the discovery and development of shared tumor-specific antigens, Epitopea is advancing treatments that harness the immune system to target and eliminate cancer cells. Our mission is to revolutionize cancer care by delivering innovative therapies that are both safe and highly effective, offering new hope to patients with hard-to-treat cancer...
    Epitopea is a biotechnology company pioneering novel cancer immunotherapies. Focused on the discovery and development of shared tumor-specific antigens, Epitopea is advancing treatments that harness the immune system to target and eliminate cancer cells. Our mission is to revolutionize cancer care by delivering innovative therapies that are both safe and highly effective, offering new hope to patients with hard-to-treat cancers. At Epitopea, we are committed to pushing the boundaries of immunotherapy, transforming the future of oncology through scientific excellence and patient-focused innovation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Epitopeaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Salisbury House, Station Road, Cambridge, Cambridgeshire
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.epitopea.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Epitopea Gets OVACT Trial Approval For CryptiVax-1001
    Epitopea Gets OVACT Trial Approval For CryptiVax-1001

    23 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-23/epitopea-announces-approval-of-ovact-clinical-trial-application-for-cryptivax-1001-in-advanced-high-grade-serous-ovarian-cancer

    PHARMIWEB
    23 Apr 2026
    Share Share
    Epitopea Bolsters Scientific Advisory Board With Cancer Expert
    Epitopea Bolsters Scientific Advisory Board With Cancer Expert

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272232/0/en/Epitopea-Strengthens-Scientific-Advisory-Board-with-Appointment-of-Leading-Authority-in-Cancer-Lisa-Butterfield.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Epitopea Adds Four Cancer Immunology Experts To Board
    Epitopea Adds Four Cancer Immunology Experts To Board

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152175/0/en/Epitopea-Strengthens-Scientific-Advisory-Board-with-Appointment-of-Four-World-Renowned-Experts-in-Cancer-Immunology-and-Immunotherapy.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    Epitopea Boosts Clinical Development and Research for Clinic
    Epitopea Boosts Clinical Development and Research for Clinic

    10 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/10/3113015/0/en/Epitopea-Expands-its-Clinical-Development-and-Research-Capabilities-as-it-Accelerates-to-the-Clinic.html

    GLOBENEWSWIRE
    10 Jul 2025
    Share Share
    Epitopea Publishes Cancer Targets Study in Nature Cancer
    Epitopea Publishes Cancer Targets Study in Nature Cancer

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088365/0/en/Epitopea-Announces-Nature-Cancer-Paper-on-Novel-Immunotherapy-Targets-in-Melanoma-and-NSCLC.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Merck's $300M-per-product collab with Epitopea to tumor antigens
    Merck's $300M-per-product collab with Epitopea to tumor antigens

    20 Feb 2025

    // BIOSPACE

    https://www.biospace.com/deals/merck-and-epitopea-join-forces-to-identify-unknown-tumor-antigens

    BIOSPACE
    20 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search